Scientists test common parasite drug on babies with scabies
NCT ID NCT05500326
Summary
This study aims to find safe and effective doses of the oral medication ivermectin for treating scabies in very young children. Researchers in Laos are measuring drug levels in the blood of 220 children, from 3 months to under 5 years old, after they take the medicine. The goal is to provide clear dosing guidelines for this vulnerable age group, where scabies can lead to serious skin infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCABIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Banchieng Health Centre
Kasy District, Vientiane Province, Laos
-
Hinngoon Health Centre
Kasy District, Vientiane Province, Laos
-
Kasy District Hospital
Kasy District, Vientiane Province, Laos
-
Poonglack Health Centre
Kasy District, Vientiane, Laos
-
ThongMeud Health Centre
Kasy District, Vientiane, Laos
Conditions
Explore the condition pages connected to this study.